Your browser doesn't support javascript.
loading
The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker.
Kang, Ka-Won; Jung, Jik-Han; Hur, Woojune; Park, Jaena; Shin, Hyunku; Choi, Byeonghyeon; Jeong, Hyesun; Kim, Dae Sik; Yu, Eun Sang; Lee, Se Ryeon; Sung, Hwa Jung; Kim, Seok Jin; Choi, Chul Won; Kim, Hyun Koo; Hong, Sunghoi; Park, Ji-Ho; Choi, Yeonho; Park, Yong; Kim, Byung Soo.
Afiliação
  • Kang KW; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Jung JH; Department of Bio and Brain Bioengineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Hur W; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Park J; Department of Bio-convergence Engineering, Korea University, Seoul, Republic of Korea.
  • Shin H; Department of Bio-convergence Engineering, Korea University, Seoul, Republic of Korea.
  • Choi B; Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine, Seoul, Republic of Korea.
  • Jeong H; School of Biosystem and Biomedical Science, Korea University, Seoul, Republic of Korea.
  • Kim DS; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Yu ES; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Lee SR; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Sung HJ; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Kim SJ; Division of Hematology-Oncology, Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Choi CW; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Kim HK; Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine, Seoul, Republic of Korea.
  • Hong S; School of Biosystem and Biomedical Science, Korea University, Seoul, Republic of Korea.
  • Park JH; Department of Bio and Brain Bioengineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Choi Y; Department of Bio-convergence Engineering, Korea University, Seoul, Republic of Korea.
  • Park Y; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea paark76@hanmail.net.
  • Kim BS; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Anticancer Res ; 38(7): 3935-3942, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29970515
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Biomarcadores Tumorais / Exossomos Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Biomarcadores Tumorais / Exossomos Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2018 Tipo de documento: Article